bioAffinity Technologies' Seed Round

bioAffinity Technologies raised a round of funding on March 09, 2017. Investors include San Antonio Economic Development Corporation.

bioAffinity Technologies is developing a diagnostic agent that aims to literally highlight cancer cells in patients sputum-basically phlegm that's coughed up from the lungs. When a synthetic molecule …

Articles about bioAffinity Technologies' Seed Round: